Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Chemotherapy

Classifying leukaemia: one size doesn’t fit all

This entry is part 18 of 19 in the series Our milestones

Many of us have a moment in our lives where everything changes irrevocably, for better or worse. A moment...

Breaking down cancer’s wall of resistance

“We really had hit a dead end.”

After countless hours of work in the lab, 2012 was a frustrating time for Professor Kairbaan Hodivala-Dilke – one of our leading...

Changing the future of pancreatic cancer: The ESPAC trials

This entry is part 16 of 16 in the series Our milestones

Mr Tilly had a tough start in life. Abandoned and unwanted, he was down on his luck. But the tide turned...

Will NICE’s proposed reforms actually work?

The way the NHS pays for new cancer drugs (not to mention radiotherapy and other treatments) is a complex and emotive issue, never far from the headlines. This is...

New drug target can break down cancer's barrier against treatment

Cancer Research UK scientists have found that targeting a molecule in blood vessels can make cancer therapy significantly more effective.

“It upset me enormously that children were dying, and I wanted to do something to help them” – Andy’s story

To coincide with the publication of our annual review, we caught up with Professor Andy Pearson, who’s leading our groundbreaking BEACON neuroblastoma trial.

From a...

“I couldn’t believe how much things had moved on” – Nicola’s story

“I went into a bit of a practical mode: this is what we need to do, everything will be fine. They sent me for further tests to see how far the cancer had spread and that’s...

Ten things politicians should do to help beat cancer

The future for people diagnosed with cancer today looks a whole lot brighter than it would have done 40 years ago.

Research has resulted in improved diagnostic...

Tumour protein predicts response to chemo in oesophageal cancer patients

Patients with the most common type of oesophageal cancer are less likely to respond to chemotherapy when their tumours are high in leptin

More oesophageal cancer patients benefit from pre-op chemo than previously thought says study

More oesophageal cancer patients than previously thought are benefiting from having chemotherapy before an operation to remove their tumour.

Pages